Abstract

Approximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.

Original languageEnglish (US)
Pages (from-to)731-738
Number of pages8
JournalJournal of Surgical Oncology
Volume105
Issue number7
DOIs
StatePublished - Jun 1 2012

Fingerprint

Malignant Pleural Effusion
Pleurodesis
Chest Tubes
Indwelling Catheters
Life Expectancy
Therapeutics
Observation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Kaifi, Jussuf T. ; Toth, Jennifer ; Gusani, Niraj J. ; Kimchi, Eric T. ; Staveley-O'Carroll, Kevin F. ; Belani, Chandra ; Reed, Michael F. / Multidisciplinary management of malignant pleural effusion. In: Journal of Surgical Oncology. 2012 ; Vol. 105, No. 7. pp. 731-738.
@article{583d9407b21f4e0098f2cba87d9ff916,
title = "Multidisciplinary management of malignant pleural effusion",
abstract = "Approximately 50{\%} of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.",
author = "Kaifi, {Jussuf T.} and Jennifer Toth and Gusani, {Niraj J.} and Kimchi, {Eric T.} and Staveley-O'Carroll, {Kevin F.} and Chandra Belani and Reed, {Michael F.}",
year = "2012",
month = "6",
day = "1",
doi = "10.1002/jso.22100",
language = "English (US)",
volume = "105",
pages = "731--738",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Multidisciplinary management of malignant pleural effusion. / Kaifi, Jussuf T.; Toth, Jennifer; Gusani, Niraj J.; Kimchi, Eric T.; Staveley-O'Carroll, Kevin F.; Belani, Chandra; Reed, Michael F.

In: Journal of Surgical Oncology, Vol. 105, No. 7, 01.06.2012, p. 731-738.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Multidisciplinary management of malignant pleural effusion

AU - Kaifi, Jussuf T.

AU - Toth, Jennifer

AU - Gusani, Niraj J.

AU - Kimchi, Eric T.

AU - Staveley-O'Carroll, Kevin F.

AU - Belani, Chandra

AU - Reed, Michael F.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Approximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.

AB - Approximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.

UR - http://www.scopus.com/inward/record.url?scp=84859897517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859897517&partnerID=8YFLogxK

U2 - 10.1002/jso.22100

DO - 10.1002/jso.22100

M3 - Review article

VL - 105

SP - 731

EP - 738

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 7

ER -